Human immuno deficiency virus better known as HIV/AIDS is one of the most catastrophic diseases/threats to the human race and health throughout the world. HIV causes AIDS. HIV was discovered in 1981, and since its existence dates back to more than 30 years, a number of changes have evolved in the market to improve the quality of life of the HIV patients. Substantial medical treatments, advancements in the medicine field, and new drug therapies have charmed the pharmaceutical industry tremendously.
Today, HIV is not considered to be a death sentence anymore. In fact, at present, the HIV market is deemed to mature, expand, and evaluate new drugs and therapies, along with numerous tested and tried treatment options to prove the effectiveness of minimizing this disease and increasing patient’s life expectancy in the best manner possible.
Different Types of HIV Drugs
With the advent of new technologies in the field of medicine, several different types of human immunodeficiency virus (HIV) medications have been introduced on the market to treat individuals diagnosed with HIV virus. These drugs are mainly obtained in the form of reverse transcriptase inhibitors, protease inhibitors, and fusion inhibitors.
For Reverse Transcriptase Inhibitors
These types of inhibitors are available in many forms. For instance, nukes are nucleoside or nucleotide reverse transcriptase inhibitors (NSTIs and NRTIs) that interfere with the reverse transcriptase enzyme to replicate. Similarly, there are non-nukes or non-nucleoside reverse transcriptase inhibitors (NNRTIs) as well.
Another group of HIV drugs which is known as integrase inhibitors act as a preventing drug to stop HIV to enter and form bonding with cells. It helps to prevent it from colonizing the cells and increasing the patient's viral load.
Moreover, the anti-retroviral therapy for HIV has tremendously oppressed the infection rates of HIV patients across the globe. In this therapy, a doctor typically prescribes drugs from two different drug classes to target the HIV virus from multiple angles.
Such a medication regimen is based on doctor’s thorough evaluations, discussions, and medical tests, describing the exact nature of the treatment(s) of the affected patients.
Challenges in the HIV Market
Even with the presence of more effective and cost-effective drug therapies for HIV, HIV drug makers face handful of difficult competition and different challenges in this market. There are several newer drugs and therapies being introduced in the market to treat HIV and they continue to earn their total income from the European, as well as the U.S. markets. But, there will be a point of time, when several leaders will begin to lose their market protection by the year 2017.
Furthermore, the highest number of HIV-infected people is witnessed in poor countries. There is a majority of the HIV infected population living in sub-Saharan Africa region. Hence, worldwide pharmaceutical companies are ensuring to lower their costs in this region so that they can introduce their products to generic competition.
The generic types of HIV drugs include didanosine, zidovudine, stavudine, and lamivudine – all of which represents 46 percent of the global HIV market.
Global Market Share and Geographic Areas Covered
The global market for HIV therapeutics and diagnostics is expected to grow to $18.2 billion in 2013, and reach a value of $19.6 billion in 2017, along with a compound annual growth rate (CAGR) of 1.5% in the given forecast period. Considering the countries covered in the global study of HIV market, places such as, the US, Germany, France, Spain, Italy, the UK, Japan, and Canada are majorly dealing with HIV patients in large numbers.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a technological growth map over time to understand the industry growth rate
- It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments